<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>2</title>
<title_fa>1</title_fa>
<short_title>3</short_title>
<subject>Literature &amp; Humanities</subject>
<web_url>http://ijwph.daneshafarand.org</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>9</journal_id_issn>
<journal_id_issn_online>10</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>7</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1405</year>
	<month>6</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2026</year>
	<month>9</month>
	<day>1</day>
</pubdate>
<volume>18</volume>
<number>3</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Assessment of MAPK4 and ERK5 as Novel diagnostic biochemical markers in systemic lupus erythematosus&#039;</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;span style=&quot;font-family:Calibri,sans-serif&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;font-family:&amp;quot;Cambria&amp;quot;,serif&quot;&gt;Background:&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;font-family:&amp;quot;Cambria&amp;quot;,serif&quot;&gt; Although anti-double-stranded DNA (dsDNA) antibodies is diagnostic markers for systemic lupus erythematosus (SLE), their limitations necessitate the identification of supplementary biologically relevant biomarkers to enhance diagnostic accuracy.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;span style=&quot;font-family:Calibri,sans-serif&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;font-family:&amp;quot;Cambria&amp;quot;,serif&quot;&gt;Objective:&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;font-family:&amp;quot;Cambria&amp;quot;,serif&quot;&gt; To evaluate serum levels of mitogen-activated protein kinase 4 (MAPK4) and extracellular signal-regulated kinase 5 (ERK5) in patients with active SLE and determine their individual and combined diagnostic performance relative to anti-dsDNA antibodies.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;span style=&quot;font-family:Calibri,sans-serif&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;font-family:&amp;quot;Cambria&amp;quot;,serif&quot;&gt;Patients and methods:&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;font-family:&amp;quot;Cambria&amp;quot;,serif&quot;&gt; This study involved 119 women with active SLE and 61 healthy female controls. Serum concentrations of MAPK4, ERK5 and the anti-dsDNA index were quantified using enzyme-linked immunosorbent assays (ELISA). Diagnostic performance was analyzed using receiver operating characteristic (ROC) curves, principal component analysis (PCA), and multivariate logistic regression.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;span style=&quot;font-family:Calibri,sans-serif&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;font-family:&amp;quot;Cambria&amp;quot;,serif&quot;&gt;Results:&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;font-family:&amp;quot;Cambria&amp;quot;,serif&quot;&gt;&amp;ensp;SLE patients showed a significant increase in MAPK4, ERK&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;font-family:&amp;quot;Cambria&amp;quot;,serif&quot;&gt;5 and anti-&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;font-family:&amp;quot;Cambria&amp;quot;,serif&quot;&gt;ds DNA levels compared with the controls (all&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;font-family:&amp;quot;Cambria&amp;quot;,serif&quot;&gt; P &lt; 0.001). The ROC curves for all have AUCs of 0.99.&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;font-family:&amp;quot;Cambria&amp;quot;,serif&quot;&gt; PCA demonstrated that the three biomarkers loaded onto a single dominant component that explained most of the variance. A logistic model&amp;ensp;combining the three markers achieved classification accuracy&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;font-family:&amp;quot;Cambria&amp;quot;,serif&quot;&gt; of 99.4 %. &lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;font-family:&amp;quot;Cambria&amp;quot;,serif&quot;&gt;The three biomarkers showed consistent behavior within the composite statistical model between them, suggesting that they are involved in a shared immunological pathway.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;span style=&quot;font-family:Calibri,sans-serif&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;font-family:&amp;quot;Cambria&amp;quot;,serif&quot;&gt;Conclusion:&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;font-family:&amp;quot;Cambria&amp;quot;,serif&quot;&gt; Serum MAPK4 and ERK5 levels were significantly elevated in active SLE, demonstrating exceptional diagnostic performance comparable to &lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;font-family:&amp;quot;Cambria&amp;quot;,serif&quot;&gt;that of anti-dsDNA antibodies. Integrating these novel kinases into a multi-marker serological panel substantially enhances the diagnostic capability for SLE, particularly when conventional mar&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;font-family:&amp;quot;Cambria&amp;quot;,serif&quot;&gt;kers yield inconclusive results.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword></keyword>
	<start_page>1001</start_page>
	<end_page>1015</end_page>
	<web_url>http://ijwph.daneshafarand.org/browse.php?a_code=A--1-128&amp;slc_lang=en&amp;sid=3</web_url>


<author_list>
	<author>
	<first_name>G.H.</first_name>
	<middle_name></middle_name>
	<last_name>Abdulhadi </last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>ghid.h.ah@comed.uobaghdad.edu.iq</email>
	<code>1003194753284600387881</code>
	<orcid>1003194753284600387881</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
